<bill session="119" type="sr" number="61" updated="2025-11-19T04:48:27Z">
  <state datetime="2025-02-05">REFERRED</state>
  <status>
    <introduced datetime="2025-02-05"/>
  </status>
  <introduced datetime="2025-02-05"/>
  <titles>
    <title type="official" as="introduced">A resolution expressing support for the continued value of arms control agreements and negotiated constraints on Russian and Chinese strategic nuclear forces.</title>
    <title type="display">A resolution expressing support for the continued value of arms control agreements and negotiated constraints on Russian and Chinese strategic nuclear forces.</title>
  </titles>
  <sponsor bioguide_id="M000133"/>
  <cosponsors>
    <cosponsor bioguide_id="K000377" joined="2025-10-28"/>
    <cosponsor bioguide_id="M001176" joined="2025-02-11"/>
    <cosponsor bioguide_id="V000128" joined="2025-09-29"/>
  </cosponsors>
  <actions>
    <action datetime="2025-02-05">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2025-02-05" state="REFERRED">
      <text>Referred to the Committee on Foreign Relations.</text>
      <reference ref="CR S673-674" label="text"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFR" name="Senate Foreign Relations" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="119" type="hr" number="100" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="International affairs"/>
  </subjects>
  <amendments/>
  <summary date="2025-03-11T18:37:40Z" status="Introduced in Senate">This resolution condemns Russia's nuclear escalatory rhetoric and implied threats on the potential use of nuclear weapons in the context of its invasion of Ukraine. The resolution also (1) condemns Russia's purported suspension of participation in the New START Treaty, (2) emphasizes the value of arms control agreements between the United States and Russia, and (3) calls on the administration to continue pursuing nuclear arms control and risk reduction with Russia and China.</summary>
</bill>
